by Benzinga Insights | Mar 6, 2026 | General
AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years by 2.09% on an annualized basis producing an average annual return of 15.03%. Currently, AbbVie has a market capitalization of $407.56 billion. Buying $1000 In ABBV: If an investor had bought $1000...
by Vandana Singh | Mar 6, 2026 | General
BioXcel Therapeutics Inc. (NASDAQ:BTAI) shares are down on Friday. The stock rallied on Thursday after the company shared positive news regarding its drug development. • BioXcel Therapeutics shares are retreating from recent levels. What’s behind BTAI decline? BXCL501...
by Chandrima Sanyal | Mar 6, 2026 | General
Autocallable ETFs, products designed to generate income using structured notes tied to equity benchmarks, have attracted nearly $1 billion in assets in less than a year. The growing popularity of this niche corner of the ETF market reflects rising investor appetite...
by Lekha Gupta | Mar 6, 2026 | General
Ondas Inc. (NASDAQ:ONDS) shares are up on Friday as the company navigates a challenging market environment. • Ondas stock is among today’s top performers. What’s behind ONDS gains? Significant New Orders Ondas has received multiple orders totaling around $6 million...
by Dylan Berman | Mar 6, 2026 | General
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) shares are trading higher Friday after the company announced that Servier will acquire it for $21.50 per share in cash. Day One Biopharmaceutical stock is trading at elevated levels. What should traders watch with DAWN?...
Recent Comments